High Sensitivity C Reactive Protein in Patients with Rheumatoid Arthritis Treated with Antibodies against IL-6 or Jak Inhibitors: A Clinical and Ultrasonographic Study
Background: We examined whether high-sensitivity CRP (hsCRP) reflected the inflammatory disease status evaluated by clinical and ultrasound (US) parameters in RA patients receiving IL-6 receptor antibodies (anti-IL-6R) or JAK inhibitors (JAKi). Methods: We conducted a cross-sectional study of patien...
Main Authors: | Beatriz Frade-Sosa, Andrés Ponce, Virginia Ruiz-Esquide, Maria Jesús García-Yébenes, Rosa Morlá, Nuria Sapena, Julio Ramirez, Ana Belen Azuaga, Juan Camilo Sarmiento, Juan D. Cañete, Jose A. Gomez-Puerta, Raimon Sanmarti |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-01-01
|
Series: | Diagnostics |
Subjects: | |
Online Access: | https://www.mdpi.com/2075-4418/12/1/182 |
Similar Items
-
Imaging Findings in Patients with Immune Checkpoint Inhibitor-Induced Arthritis
by: Andrés Ponce, et al.
Published: (2022-08-01) -
Calprotectin in Patients with Rheumatic Immunomediated Adverse Effects Induced by Checkpoints Inhibitors
by: Beatriz Frade-Sosa, et al.
Published: (2023-05-01) -
Efficacy and Safety of JAK1 Inhibitor Abrocitinib in Atopic Dermatitis
by: Helena Iznardo, et al.
Published: (2023-01-01) -
Refractory granuloma faciale successfully treated with adjunct topical JAK inhibitor
by: Ailynna Chen, MPH, et al.
Published: (2023-03-01) -
Finding a Jill for JAK: Assessing Past, Present, and Future JAK Inhibitor Combination Approaches in Myelofibrosis
by: Andrew T. Kuykendall, et al.
Published: (2020-08-01)